Tech Company Financing Transactions

CoAxia Funding Round

CoAxia, operating out of Maple Grove, secured $11.5 million from Canaan Partners, Affinity Capital and Baird Capital.

Transaction Overview

Company Name
CoAxia
Announced On
4/3/2008
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Series C
Investors

Canaan Partners (Lead Investor) (Brent Ahrens)

Affinity Capital (Kristine Johnson)

Baird Capital (Peter Shagory)

Johnson & Johnson Development Corporation (Roger Guidi)

Prism VentureWorks (Gordie Nye)

Proceeds Purpose
Andrew M. Weiss, President and CEO commented, "We are grateful for the support from our current investors, who, with the conclusion of this C Round extension, have invested more than $30M in CoAxia and the NeuroFlo technology. Our objective for the coming 24 months is to finish enrollment in our SENTIS pivotal trial, demonstrate the feasibility of NeuroFlo in several large stroke patient populations, and begin positioning CoAxia for future commercialization."

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10900 73rd Ave. North 102
Maple Grove, MN 55369
USA
Phone
(763) 315-1809
Website
www.coaxia.com
Email Address
[email protected]
Overview
CoAxia, Inc., a Maple Grove, MN-based, privately held, development-stage medical device company, is pioneering the use of catheter-based perfusion augmentation systems for the treatment of cerebral ischemia.
Profile
CoAxia LinkedIn Company Profile
Social Media
CoAxia Company Twitter Account
Company News
CoAxia News
Facebook
CoAxia on Facebook
YouTube
CoAxia on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Weiss
  Andrew Weiss LinkedIn Profile  Andrew Weiss Twitter Account  Andrew Weiss News  Andrew Weiss on Facebook
VP - Finance
Shelby Hautman
  Shelby Hautman LinkedIn Profile  Shelby Hautman Twitter Account  Shelby Hautman News  Shelby Hautman on Facebook
VP - Marketing
Richard Schallhorn
  Richard Schallhorn LinkedIn Profile  Richard Schallhorn Twitter Account  Richard Schallhorn News  Richard Schallhorn on Facebook
VP - Regulatory Affairs
Sharon Kvistad
  Sharon Kvistad LinkedIn Profile  Sharon Kvistad Twitter Account  Sharon Kvistad News  Sharon Kvistad on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/3/2008: Lavante venture capital transaction
Next: 4/4/2008: Coremetrics venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.